BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 117 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,000 | -75.0% | 16 | -75.8% | 0.00% | – |
| Q2 2020 | $4,000 | +100.0% | 66 | +106.2% | 0.00% | – |
| Q1 2020 | $2,000 | +100.0% | 32 | +357.1% | 0.00% | – |
| Q3 2019 | $1,000 | -95.8% | 7 | -98.3% | 0.00% | – |
| Q2 2019 | $24,000 | -14.3% | 407 | -10.5% | 0.00% | – |
| Q1 2019 | $28,000 | -3.4% | 455 | -6.2% | 0.00% | – |
| Q4 2018 | $29,000 | -23.7% | 485 | -24.8% | 0.00% | – |
| Q3 2018 | $38,000 | +2.7% | 645 | -21.9% | 0.00% | – |
| Q2 2018 | $37,000 | +164.3% | 826 | +169.9% | 0.00% | – |
| Q1 2018 | $14,000 | +133.3% | 306 | +152.9% | 0.00% | – |
| Q2 2017 | $6,000 | -64.7% | 121 | -60.8% | 0.00% | – |
| Q1 2017 | $17,000 | +112.5% | 309 | +76.6% | 0.00% | – |
| Q3 2015 | $8,000 | +700.0% | 175 | +2400.0% | 0.00% | – |
| Q1 2015 | $1,000 | -75.0% | 7 | -94.0% | 0.00% | – |
| Q4 2014 | $4,000 | -63.6% | 116 | -62.2% | 0.00% | – |
| Q3 2014 | $11,000 | 0.0% | 307 | -23.6% | 0.00% | – |
| Q2 2014 | $11,000 | – | 402 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 73,649 | $3,646,000 | 2.32% |
| Stonepine Capital Management, LLC | 59,878 | $2,965,000 | 1.60% |
| NORTHPOINTE CAPITAL LLC | 109,644 | $5,428,000 | 0.57% |
| Elk Creek Partners, LLC | 145,406 | $7,199,000 | 0.47% |
| TFS CAPITAL LLC | 18,208 | $901,000 | 0.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 161,671 | $8,004,000 | 0.35% |
| Ativo Capital Management LLC | 19,592 | $970,000 | 0.26% |
| Matarin Capital Management, LLC | 57,034 | $2,823,753,000 | 0.26% |
| ISTHMUS PARTNERS, LLC | 16,505 | $817,000 | 0.24% |
| Stanley-Laman Group, Ltd. | 12,546 | $621,000 | 0.17% |